-
公开(公告)号:DK1648905T3
公开(公告)日:2009-03-30
申请号:DK04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:ES2319302T3
公开(公告)日:2009-05-06
申请号:ES04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Un compuesto de fórmula (I) ** ver fórmula** o una sal terapéuticamente aceptable del mismo, donde R 1 se selecciona del grupo que consiste en alcoxialquinilo, alcoxicarbonilalquenilo, alcoxicarbonil-alquilo, alquinilo, arilo, arilalquinilo, alcoxi-alquinilo, arilsulfanilalquinilo, carboxialquenilo, carboxialquilo, carboxialquinilo, cianoalquilo, cicloalquilalquinilo, formilalquenilo, halo, heteroarilo, heteroarilalquinilo, heteroarilcarbonilalquenilo, hetero-arilcarbonilalquilo, heterociclilalquenilo, heterociclil-alquilo, heterociclilalquinilo, heterociclilcarbonil-alquenilo, hidroxialquenilo, hidroxialquilo, hidroxialquinilo, NR a R b , (NR a R b )alquenilo, (NR a R b )alquilo, (NR a R b )alquilo, (NR a R b )carbonilalquenilo, (NR a R b )carbonil-alquilo, y nitro; R 2 se selecciona del grupo que consiste en hidrógeno y alquilo; R 3 se selecciona del grupo que consiste en halo, arilo, heteroarilo, y heterociclilo, donde arilo, heteroarilo, y el heterociclilo están sustituidos opcionalmente con uno, dos, o tres sustituyentes seleccionados independientemente del grupo que consiste en alcoxi, alquilo, arilo, ciano, halo, haloalcoxi, haloalquilo, heteroarilo, hidroxialquilo, LR 4 , y NR a R b ; siempre que al menos dos de los tres sustituyentes sean distintos de LR 4 ; L se selecciona del grupo que consiste en O, NR 5 C(O)(CH2)m, NR 5 SO2, y (CH2)mN(R 5 )C(O)N(R 5 )(CH2)a, donde m y n son 0 1 y donde cada grupo se representa con su extremo derecho anclado a R 4 ; R 4 se selecciona del grupo que consiste en arilo, arilalquilo, heteroarilo, y heterociclilo; R 5 y R 6 son hidrógeno; R a y R b se seleccionan independientemente del grupo que consiste en hidrógeno, alquilo, alquilcarbonilo, alquilsulfonilo, cicloalquilo, heterociclilcarbonilo, (NR a R b )alquilcarbonilo, y R a y R d se seleccionan independientemente del grupo que consiste en hidrógeno, y alquilo, donde heteroarilo se selecciona entre benzimidazolilo, benzoxadiazolilo, benzoxazolilo, benzofuranilo, benzisoxazolilo, benzotiazolilo, benzotienilo, cinnolinilo, dibenzofuranilo, furanilo, furilo, imidazolilo, indazolilo, indolilo, isoxazolilo, isoquinolinilo, isotiazolilo, naftiridinilo, oxadiazolilo, oxadiazolilo, oxazolilo, piridinilo, piridazinilo, pirimidinilo, pirazinilo, pirazolilo, pirrolilo, quinolinilo, tiazolilo, tienopiridinilo, tienilo, triazolilo, tiadiazolilo, y triazinilo, y donde heterociclilo se selecciona entre azetidinilo, benzodioxolilo, benzotiazolilo, diazepanilo, dihidroindolilo, dihidroisoindolilo, dihidropiridinilo, 1,3-dioxanilo, 1,4-dioxanilo, 1,3-dioxolanilo, isoindolinilo, morfolinilo, piperazinilo, pirrolidinilo, tetrahidropiridinilo, piperidinilo, y tiomorfolinilo, diazepinilo, imidazolidinilo, morfolinilo.
-
公开(公告)号:PT1648905E
公开(公告)日:2009-04-08
申请号:PT04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: DAVIDSEN STEVEN K , CURTIN MICHAEL L , MICHAELIDES MICHAEL R , BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4353 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/00 , C07D491/04 , C07D495/00 , C07D498/00 , C07D498/04
-
公开(公告)号:CY1111599T1
公开(公告)日:2015-10-07
申请号:CY091100278
申请日:2009-03-12
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Ενώσειςπουέχουντονχημικότύπο: (I), είναιχρήσιμεςγιατηναναστολήκινασώντυροσίνηςπρωτεΐνης. Στηνπαρούσαεφεύρεσηαποκαλύπτονταικαιδημοσιοποιούνταιωςαναφοράεπίσηςμέθοδοιγιατηνπαρασκευήτωνενώσεων, τωνσυνθέσεωνπουπεριέχουντιςενώσεις, καιτωνμεθόδωναγωγήςχρησιμοποιώνταςτιςενώσεις.
-
公开(公告)号:NZ544712A
公开(公告)日:2009-09-25
申请号:NZ54471204
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Disclosed are compounds of formula (I) wherein: X is S; Z is C; R1 and R3 are as described in the specification; and R2 is hydrogen or alkyl. Compounds of the type disclosed are tyrosine kinase inhibitors useful in the treatment of cancer.
-
公开(公告)号:BRPI0412894A
公开(公告)日:2006-10-03
申请号:BRPI0412894
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: A61P35/00 , C07D491/04 , C07D495/04 , C07D498/04 , A61K31/4355 , A61K31/4365
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:AU2004259765A1
公开(公告)日:2005-02-03
申请号:AU2004259765
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: HRNCIAR PETER , DAVIS HEATHER M , BURCHAT ANDREW F , WADA CAROL K , HEYMAN HOWARD R , HIRST GAVIN C , FREY ROBIN R , RAFFERTY PAUL , CALDERWOOD DAVID J , CURTIN MICHAEL L , MUCKEY MELANIE A , DAVIDSEN STEVEN K , MICHAELIDES MICHAEL R , BETSCHMANN PATRICK
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:CA2532982C
公开(公告)日:2013-11-26
申请号:CA2532982
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula: (I), are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:SI1648905T1
公开(公告)日:2009-06-30
申请号:SI200431056
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/00 , A61K31/00 , A61P35/00 , C07D491/00 , C07D491/04 , C07D495/04 , C07D498/00
-
公开(公告)号:CA2532982A1
公开(公告)日:2005-02-03
申请号:CA2532982
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , HEYMAN HOWARD R , MUCKEY MELANIE A , HIRST GAVIN C , RAFFERTY PAUL , BETSCHMANN PATRICK , HRNCIAR PETER , MICHAELIDES MICHAEL R , BURCHAT ANDREW F , CALDERWOOD DAVID J , WADA CAROL K , FREY ROBIN R
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula: (I), are useful for inhibiting protein tyrosin e kinases. The present invention also discloses methods of making the compound s, compositions containing the compounds, and methods of treatment using the compounds.
-
-
-
-
-
-
-
-
-